About
Advanced Bifurcation Systems Inc. (ABS) is a medical device company based in Livermore, California, founded in 2025. The company specializes in innovative solutions for coronary artery disease, particularly focusing on bifurcation lesions during coronary angioplasty procedures. ABS is developing a dedicated stent delivery system designed to treat these complex cases, which are often challenging and associated with less favorable outcomes. The flagship product is an FDA Class III medical device platform that has received FDA Breakthrough Device designation, indicating its potential to address significant needs in interventional cardiology. ABS aims to enhance the treatment of left main heart disease and other bifurcation-related conditions, with plans for commercialization following regulatory approvals in the U.S. and internationally. The company serves interventional cardiologists, hospitals, and healthcare providers who require advanced tools for complex coronary interventions.
Technologies
Keywords
Company Information
-
Employees 17
-
Founded 2010
-
Total Funding $31800000
Location
7419 Southfront Rd, Livermore, California, United States, 94551-8224
